Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
720
Trial Sponsor
Clinical Trial Start Date
2006
0Primary Completion Date
2007
0Study Completion Date
2007
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Interventional Trial Phase
Phase 20
Official Name
A Phase 2 Study of Recombinant Human Thrombin (rThrombin) Administered Using a Spray Applicator in Subjects Undergoing Autologous Skin Grafting Following Burn or Traumatic Skin Injury0
Last Updated
March 9, 2009
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
rThrombin0
Study summary
The purpose of this study is to evaluate whether rThrombin is safe when used for controlling bleeding during skin graft surgery.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
